Konstan, M., Wagener, J., Yegin, A., Millar, S., Pasta, D., & VanDevanter, D. (2010). DESIGN AND POWERING OF CYSTIC FIBROSIS CLINICAL TRIALS USING RATE OF FEV(1) DECLINE AS AN EFFICACY ENDPOINT.
Stile di citazione ChicagoKonstan, MW, JS Wagener, A. Yegin, SJ Millar, DJ Pasta, e DR VanDevanter. DESIGN AND POWERING OF CYSTIC FIBROSIS CLINICAL TRIALS USING RATE OF FEV(1) DECLINE AS AN EFFICACY ENDPOINT. 2010.
Citazione MLAKonstan, MW, et al. DESIGN AND POWERING OF CYSTIC FIBROSIS CLINICAL TRIALS USING RATE OF FEV(1) DECLINE AS AN EFFICACY ENDPOINT. 2010.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.